Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardiology and Angiology 2021 April;69(2) > Minerva Cardiology and Angiology 2021 April;69(2):201-14

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Cardiology and Angiology 2021 April;69(2):201-14

DOI: 10.23736/S2724-5683.20.05167-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

STENTYS coronary system: current status and future direction

Marco GOLINO 1, Silvia NUZZO 2, Carlo BRIGUORI 1

1 Interventional Cardiology Unit, Mediterranea Cardiocentro, Naples, Italy; 2 IRCCS SDN, Naples, Italy



Stentys self-apposing stent was designed to face complex lesions in the precincts of percutaneous coronary interventions. Nitinol platform and disconnectable struts were designed to provide a complete apposition on the vessel wall in challenging lesions such as significant tapering, primary angioplasty in ST segment elevation myocardial infarction and bifurcation. Stentys X-position S is a sirolimus eluting stent with a novel delivery system aiming to improve positioning. Clinical trials showed good results in terms of procedural success rate, clinical outcome and short-term strut apposition. Nevertheless, Stentys stent did not show superiority over the conventional balloon-expandable stents in the clinical outcomes. Authors underlined the importance of a learning curve and an adequate training period to get familiar with the device’s features. Future trials in an all-comer population using the novel X-Position S stent will confirm the preliminary findings and strengthen evidence in clinical practice.


KEY WORDS: Stents; Percutaneous coronary intervention; Heart

top of page